HERPABLOC
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

HERPABLOC Trademark

Serial Number: 77293843

HERPABLOC is a trademark filed by HerbalScience Nutraceuticals, LLC on October 2, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

HerbalScience Nutraceuticals, LLC

1004 Collier Center Way, Suite 200
Naples, FL 34110

Entity Type: 16

Trademark Details

Filing Date

October 2, 2007

Registration Date

Not Registered

Published for Opposition

April 14, 2009

Goods & Services

Nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products, namely, ointments, oils, drinks, infusions, syrups, poisons, tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, herbal extracts and syrups; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aroma therapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, aromatherapy packs used for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer or related conditions; nutritional dietary supplements; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for medically restricted diets; food supplements, namely, anti-oxidants; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use; botanical extracts as component ingredients of nutraceuticals and pharmaceuticals for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer or related conditions; botanical extracts sold as an integral ingredient of nutritional supplements, nutraceuticals and pharmaceuticals; anti-cough drops; cough drops; cough expectorants; cough lozenges; cough syrups; cough treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; cold sore treatment preparations; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical preparations in the form of capsules for the treatment of herpes simplex infection; homeopathic pharmaceutical preparations for the treatment of herpes and cold sores; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, hiv retinopathy, herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus, "herpes zoster" "shingles", cytomegalovirus, cold sores, human immune deficiency virus "hiv", roseola infantum, human herpes iv; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and aids; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type II or herpes zoster virus, not in intravenous form; and water based food supplement beverages

Botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 9, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 9, 2010 ABN6
SOU EXTENSION 1 GRANTED
Jan 26, 2010 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 26, 2010 AITU
SOU EXTENSION 1 FILED
Dec 14, 2009 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 14, 2009 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2009 NOAM
PUBLISHED FOR OPPOSITION
Apr 14, 2009 PUBO
NOTICE OF PUBLICATION
Mar 25, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 9, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2009 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 6, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 13, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 3, 2009 PREV
ASSIGNED TO LIE
Feb 3, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2009 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 22, 2009 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 22, 2008 GNFN
FINAL REFUSAL E-MAILED
Aug 22, 2008 GNFR
FINAL REFUSAL WRITTEN
Aug 22, 2008 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 14, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jan 14, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jan 14, 2008 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2008 DOCK
NEW APPLICATION ENTERED
Oct 5, 2007 NWAP